ECBF has supplied an extension to Aphea.Bio’s series B round, which already included Gemma Frisius Fund, Qbic, Vives and V-Bio Ventures.

Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.

UVC Partners has led a $21m series B round for Wire.

Orbia Ventures led a round for the battery production technology provider that emerged out of Worcester Polytechnic Institute.

GV returned for a series B round that increased the overall funding for Stanford’s machine learning technology developer to $50m.

The Engine was among the returning investors for the Rice spinout’s series B round, having previously backed a series A in 2019.

Lyell Immunopharma co-led a series A round for the gene therapy developer, which partially exploits UW research.

Cash Capital has returned for OnQuality Pharmaceuticals’s latest round, having already participated in a $15m series A in 2019.

Orange and Deutsche Telekom Capital Partners both chipped in as the Ben-Gurion spinout looks to ramp up hiring.

The spinout of Yamaguchi University and National Cancer Centre Japan has raised the cash from investors including Dai-ichi Life and Binex.